Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy. (Q44295790)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189371%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189371%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189371%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Salvatore Siena

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189371%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Stefano Cascinu

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189371%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189371%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Eric Van Cutsem

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189371%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Alberto Sobrero

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189371%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Alain Hendlisz

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189371%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Giovanna Devercelli

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189371%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Michael Wolf

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189371%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Rafael G Amado

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189371%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

0 references

publication date

1 April 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189371%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189371%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

115

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189371%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189371%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1544-1554

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189371%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of cutaneous toxicities to EGFR inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical detection of the epidermal growth factor receptor in paraffin-embedded human tissues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

EGFR and cancer prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

What Are the Most Important Symptom Targets When Treating Advanced Cancer? A Survey of Providers in the National Comprehensive Cancer Network (NCCN)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Methods for handling missing data in palliative care research

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24088

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44295790&oldid=2138134595"